Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Summary

Singular Genomics Systems (Nasdaq: OMIC) has announced a rescheduled time for its fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit. The event will now take place at 8:00 a.m. PT on August 11, 2022. Interested parties can listen to the live and recorded webcast at their investor relations website. Singular Genomics focuses on developing next-generation sequencing and multiomics technologies, with its G4 Sequencing Platform already available and a new PX system in development.

Positive

• Scheduled presentation at a significant summit may enhance visibility.
• Company develops advanced next-generation sequencing and multiomics technologies.

Negative

• None.

Fireside chat now scheduled for 8:00am PT on Thursday, August 11, 2022

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced its presentation time at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California has been rescheduled.

The new time for the fireside chat is 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time on the same day as previously scheduled, Thursday, August 11, 2022. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

What is Singular Genomics' new presentation time at the UBS Summit?

The fireside chat is rescheduled to 8:00 a.m. PT on August 11, 2022.

Where can I listen to the webcast of Singular Genomics' presentation?

The webcast can be accessed at investor.singulargenomics.com.

What technologies does Singular Genomics focus on?

Singular Genomics specializes in next-generation sequencing and multiomics technologies.

What is the G4 Sequencing Platform?

The G4 Sequencing Platform is a versatile benchtop genomic sequencer developed by Singular Genomics.

What is the PX system being developed by Singular Genomics?

The PX system is a technology leveraging proprietary sequencing methods for in-situ readouts of RNA and proteins in single cells and tissues.